GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolase Inc (NAS:BIOL) » Definitions » Shiller PE Ratio

Biolase (Biolase) Shiller PE Ratio : (As of Apr. 28, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Biolase Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biolase Shiller PE Ratio Historical Data

The historical data trend for Biolase's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolase Shiller PE Ratio Chart

Biolase Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biolase Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biolase's Shiller PE Ratio

For the Medical Devices subindustry, Biolase's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolase's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biolase's Shiller PE Ratio falls into.



Biolase Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biolase's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Biolase's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-6.532/129.4194*129.4194
=-6.532

Current CPI (Dec. 2023) = 129.4194.

Biolase Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -1,525.380 99.695 -1,980.187
201406 -1,994.730 100.560 -2,567.204
201409 -938.697 100.428 -1,209.681
201412 -938.697 99.070 -1,226.264
201503 -1,056.030 99.621 -1,371.906
201506 -1,408.050 100.684 -1,809.912
201509 -1,056.030 100.392 -1,361.378
201512 -469.349 99.792 -608.692
201603 -821.360 100.470 -1,058.022
201606 -704.023 101.688 -896.017
201609 -1,056.030 101.861 -1,341.738
201612 -821.360 101.863 -1,043.561
201703 -750.000 102.862 -943.637
201706 -1,525.000 103.349 -1,909.688
201709 -750.000 104.136 -932.098
201712 -525.000 104.011 -653.249
201803 -625.000 105.290 -768.235
201806 -600.000 106.317 -730.380
201809 -575.000 106.507 -698.699
201812 -825.000 105.998 -1,007.294
201903 -575.000 107.251 -693.854
201906 -450.000 108.070 -538.901
201909 -625.000 108.329 -746.677
201912 -325.000 108.420 -387.947
202003 -475.000 108.902 -564.494
202006 -300.000 108.767 -356.962
202009 -525.000 109.815 -618.725
202012 -175.000 109.897 -206.088
202103 -138.000 111.754 -159.814
202106 -12.000 114.631 -13.548
202109 -54.000 115.734 -60.385
202112 -75.000 117.630 -82.517
202203 -81.000 121.301 -86.421
202206 -91.980 125.017 -95.219
202209 -110.360 125.227 -114.055
202212 -128.000 125.222 -132.291
202303 -18.000 127.348 -18.293
202306 -8.930 128.729 -8.978
202309 -3.890 129.860 -3.877
202312 -6.532 129.419 -6.532

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biolase  (NAS:BIOL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biolase Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Biolase's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolase (Biolase) Business Description

Traded in Other Exchanges
Address
27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Lord Jonathan T Md director 500 WEST MAIN ST., LOUISVILLE KY 40202
Jennifer Bright officer: Chief Financial Officer 27042 TOWNE CENTRE DRIVE,, SUITE 270, FOOTHILL RANCH CA 92610
Steven Sandor officer: Chief Operating Officer 27042 TOWNE CENTRE DRIVE,, SUITE 270, FOOTHILL RANCH CA 92610
Jess Roper director 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Kenneth P. Yale director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
John R Beaver director, officer: President & CEO C/O STERLING CHEMICALS INC, 1200 SMITH STREET, HOUSTON TX 77002
Kathleen T Oloughlin director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
Somerman Martha J. Dds, Phd director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
Summerhays Carol Gomez Dds director 27042 TOWN CENTRE DRIVE, SUITE 270, FOOTHILL RANCH CA 92610
Family Foundation Schuler 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Larry N Feinberg 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Jack W Schuler 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Michael Ditolla director 3299 CAMBRIDGE AVE, BRONX NY 10463